Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

sandoz

Novartis enters biosimilar agreement with Biocon

January 19, 2018 Medical Communications, Sales and Marketing Biocon, Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

Novartis’ Sandoz unit had already staked a claim to being one of the leaders in the developing biosimilar market and …
News
pfizer-building-logo1web

Pfizer’s Xalkori sees rejection at the hands of NICE in lung cancer

January 19, 2018 Medical Communications, Sales and Marketing Cancer, NCIE, NSCLC, Pfizer, UK, Xalkori, lung cancer, pharma

UK regulator NICE has announced its decision not to recommend Pfizer’s Xalkori (crizotinib) for use on the NHS in the …
News
astrazeneca-sign

AstraZeneca expands drug discovery collaboration with X-Chem

January 18, 2018 Research and Development, Sales and Marketing AstraZeneca, X-Chem, pharma

AstraZeneca and X-Chem are to expand their existing drug discovery collaboration, it has emerged. The partnership marks the third agreement …
News
sunrise-1756274_960_720

Riding the wave: The FDA and real world evidence

January 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, real world evidence

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …
Feature
darzalex

NICE meets Janssen halfway over Darzalex

January 18, 2018 Medical Communications, Sales and Marketing J&J, JJ, Janssen, biotech, darzalex, drugs, pharma, pharmaceutical

NICE rejected Janssen’s Darzalex (Daratumumab) back in March last year, concluding that it wasn’t able to accurately determine the efficacy …
News
novartis_outside_1

Novartis’ CAR T therapy Kymriah scores accelerated approval in both Europe and US

January 17, 2018 Research and Development, Sales and Marketing CAR T, CAR-T, EMA, Europe, FDA, Kymriah, Novartis, US, pharma

Following up last year’s ground-breaking news that CAR T therapy Kymriah had become the first such treatment to be approved …
News
celgene_1_02

Celgene rumoured to be revving up for Juno buyout

January 17, 2018 Research and Development, Sales and Marketing CAR-T, Celgene, Juno, biotech, drugs, pharma, pharmaceutical

Celgene has already started off the year with a bang, announcing a deal with Impact Biomedicines worth a potential $7 …
News
filippo_6_for_internal_use_online

GSK Consumer Healthcare announces new Asia Pacific Regional Head

January 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline

GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific, overseeing …
Appointment
surinder

Hikma bring in new CSO

January 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hikma, biotech, drugs, pharma, pharmaceutical

Hikma Pharmaceuticals has announced that Surendera Tyagi is being brought in to join the company as Group Chief Scientific Officer …
Appointment

Boehringer’s Gilotrif approved in US for lung cancer with non-resistant EGFRs

January 16, 2018 Manufacturing and Production, Sales and Marketing Boehringer Ingelheim, Cancer, FDA, Giltrif, NSCLC, lung cancer

Boehringer Ingelheim is celebrating the FDA’s decision to expand the indication of its lung cancer drug Gilotrif (afatinib) to include …
News
teva_canada_1

FDA expands indication of Teva’s Trisenox for acute promyelocytic leukaemia

January 16, 2018 Manufacturing and Production, Sales and Marketing FDA, Teva, acute promyelocytic leukaemia, leukaemia, pharma

Teva has announced that its Trisenox (arsenic trioxide) injection has been awarded US approval from the FDA in combination with …
News
heartbeat-3077960_960_720

Seizing opportunities in the next steps for real world evidence

January 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Real world evidence is high on the agenda at many conferences, as people mull over the possibilities that it may …
Feature
gavel_2

Teva settles with Israeli authorities over international bribery

January 15, 2018 Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical

Just over a year ago, Teva closed a case with US authorities by agreeing to pay a $519 million fine …
News
shire_image_4

Shire scores European approval for Adynovi in haemophilia A

January 15, 2018 Sales and Marketing Adynovi, Europe, European Commission, Shire, haemophilia, haemophilia a, pharma

Shire has revealed that the European Commission has approved Adynovi (antihaemophilic factor (recombinant), PEGylated) for on-demand and prophylactic use in …
News
philippines-1195394_960_720

Sanofi agrees to reimburse Philippines’ Dengvaxia stockpiles

January 15, 2018 Sales and Marketing Philippines, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi has agreed with the Department of Health (DoH) for the Philippines to reimburse $27.86 million worth of vaccines, though …
News
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026